Latest News
29-May-2025 Flush Expired, Unused Opioids Down the Toilet, says Regulator
27-May-2025 Novartis Offers Payment Plan for High-cost Heart Medicine
23-May-2025 Zydus Working on Single Pen Device for Adjustable Semaglutide Doses
23-May-2025 Sun Pharma Net Falls 19% in Q4, Sales Rise
22-May-2025 Small Pharma Firms Have a Big Problem of Substandard Drugs
  more...
Latest Reports
Apr-25 4QFY25 Preview: Focus on Domestic Plus Margin Variance - Emkay Research  
Apr-25 HSIE Research is also available on Bloomberg ERH HDF & Thomson Reuters Pharma dodges first round of US tariff risk - HDFC Securities  
Jan-25 March of corporate hospitals: Deepening presence - Emkay Research  
Jan-25 US pricing pressure eases; margins improve - Nirmal Bang  
Jan-25 Chemicals/Pharma EXIM trends - Phillip Capital  
  more...

Quarterly Summary March-2025
Desc Current Previous Per.Chg
Sales 29848.7 26038.6 14.6
Otherincome 1172.6 1168.1 0.4
Expense 22400.1 20728.5 8.1
RawMaterial 7428.0 6893.5 7.8
StaffCost 4279.7 3940.9 8.6
ExciseDuty 19.9 13.3 49.6
OtherExp 7136.3 6659.6 7.2
Interest 270.9 202.9 33.5
GrossProfit 9016.7 6956.6 29.6
Depreciation 1165.2 1182.3 -1.4
Tax 1674.7 1362.7 22.9
NetProfit 6581.1 4343.9 51.5
Total.Comp 45 -- --
Source: ETIG Database

Sectoral Companies As on 30 May 2025
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 402674.52
Divi's Lab 175519.52
Cipla 118308.61
Torrent Phar 107419.16
Dr.Reddy's 104458.54
Mankind Phar 102062.80
Zydus Life 93561.51
Lupin 89420.54
Aurobindo Ph 67232.03
Abbott (I) 64712.94
Alkem Labora 60919.09
GlaxoSmith.P 55820.59
Glenmark Pha 41137.71
  click here for the complete list